Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Accenture CEO of the Americas Receives RSU Grant

A statement of changes in beneficial ownership filed on August 17, 2026, disclosed that John F. Walsh, CEO-The Americas at Accenture plc (NYSE:ACN), acquired 24 Class A ordinary shares through an anti-dilution RSU grant on August 14, 2026.

Nitish Kishor | 17 August 2026

Accenture Director Receives 15 RSUs in Anti-Dilution Grant

A Form 4 filed on August 17, 2026, reports that Tracey Thomas Travis, a director of Accenture plc (NYSE:ACN), acquired 15 Class A ordinary shares through a restricted share unit grant on August 14, 2026.

Aditi Sarkar | 17 August 2026

Accenture Director Receives 9 RSUs in Anti-Dilution Grant

Martin Brudermueller, a director of Accenture plc, filed a Form 4 on August 17, 2026, disclosing the acquisition of 9 Class A ordinary shares in the form of Restricted Share Units granted on August 14, 2026.

Aakashdeep | 17 August 2026

Granite Ridge Resources Director Buys 1,000 Shares

A statement of changes in beneficial ownership filed on August 17, 2026 reported that Michele J. Everard, a director of Granite Ridge Resources, Inc. (NYSE:GRNT), purchased 1,000 shares of common stock on August 13, 2026.

Anjali Anand | 17 August 2026

DexCom EVP Sells 1,700 Shares Under 10b5-1 Plan

Michael Jon Brown, Executive Vice President and Chief Legal Compliance Officer of DexCom Inc (NASDAQ:DXCM), filed a Form 4 on August 17, 2026, reporting the sale of 1,700 shares of common stock on August 14, 2026, pursuant to a pre-established 10b5-1 trading plan.

Aditi Sarkar | 17 August 2026

Powell Industries Director Sells 2,250 Shares at $203.05

A Form 4 filed with the SEC on August 17, 2026 discloses that Richard E. Williams, a director of Powell Industries Inc (NASDAQ:POWL), sold 2,250 shares of common stock on August 14, 2026 at a price of $203.05 per share pursuant to a Rule …

Aakashdeep | 17 August 2026

Kura Oncology CEO Buys 100,000 Shares at $11.12

Troy Edward Wilson, President and CEO of Kura Oncology, Inc. (NASDAQ:KURA), filed a Form 4 on August 17, 2026, disclosing the open-market purchase of 100,000 shares of common stock at a weighted average price of $11.12 per share.

Nitish Kishor | 17 August 2026

Remitly Global Director Sells 31,000 Shares in Two Days

A Form 4 filed on August 17, 2026, with the SEC reports that Nigel W. Morris, a director of Remitly Global, Inc. (NASDAQ:RELY), sold a combined 31,000 shares of common stock on August 13 and August 14, 2026.

Shwetambri Chauhan | 17 August 2026

OSI Systems Director Reports Share Withholding Transaction

A Form 4 filed with the SEC on August 17, 2026 discloses that Kelli Bernard, a director of OSI Systems Inc, had 126 shares of common stock withheld on August 14, 2026 to satisfy tax obligations related to a net settlement.

Nitish Kishor | 17 August 2026

OSI Systems Director Reports Share Withholding Transaction

Director Gerald M. Chizever filed a Form 4 with the SEC on August 17, 2026, disclosing a net settlement share withholding transaction in OSI Systems Inc common stock dated August 14, 2026.

Aakashdeep | 17 August 2026
Support

Hi! How can we help you today?

Loading…